Breaking news and information from the CDC, FDA and medical journals.
Suggested potential activity of nab-paclitaxel plus gemcitabine against locally advanced pancreatic cancer.
Read MoreThe potentially distinct contribution to ESKD of heart failure with preserved versus reduced ejection fraction deserves future investigation.
Read MoreADHD often co-occurs with intellectual disability, and shared overlapping genetics have been suggested.
Read MoreLength of procedure, blood loss, and oxygen saturations are additional risk factors associated with RBCT.
Read MoreThere is no observable difference between the incubation time for SARS-CoV-2, SARS and MERS, highlighting the need for larger and well annotated datasets.
Read MoreEMPA effectively reduces hepatic fat in patients with T2D with excellent glycemic control and short known disease duration.
Read MoreTreatment of patients at risk for ischemia-reperfusion injury and delayed graft function with C1 esterase inhibitor was associated with a lower incidence of graft failure.
Read MorePurpose is to identify textural features that differ between cervical tumors above and below the volume threshold of eligibility for trachelectomy.
Read MoreFor a drug to switch to nonprescription status, the data provided must demonstrate that the drug is safe and effective for use in self-medication
Read MoreConservative management of primary spontaneous pneumothorax was noninferior to interventional management, with a lower risk of serious adverse events.
Read More